Scynexis (SCYX) Operating Expenses (2013 - 2026)
Scynexis' (SCYX) quarterly Operating Expenses came in at $16.9 million in Q1 2026, up 91.03% YoY from $8.9 million in Q1 2025, and up 108.48% on a QoQ basis from $8.1 million in Q4 2025.
Scynexis (SCYX) Operating Expenses (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has 14 years of Operating Expenses data on file, last reported at $16.9 million in Q1 2026.
- Quarterly Operating Expenses rose 91.03% year-over-year to $16.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $44.7 million (up 15.13% YoY) and the FY2025 annual result came in at $36.7 million, down 10.25% from the prior year.
- Operating Expenses advanced to $16.9 million in Q1 2026, from $8.1 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $28.9 million in Q4 2023 to a low of $8.1 million in Q4 2025.
- A 5-year average of $14.9 million and a median of $11.8 million in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2024 — Operating Expenses sank 68.71% — and 2026, when it soared 91.03%.
- Tracing SCYX's Operating Expenses over 5 years: stood at $24.0 million in 2022, then increased by 20.23% to $28.9 million in 2023, then slumped by 68.71% to $9.0 million in 2024, then fell by 10.02% to $8.1 million in 2025, then soared by 108.48% to $16.9 million in 2026.
- The last three Operating Expenses figures came in at $16.9 million (Q1 2026), $8.1 million (Q4 2025), and $8.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Scynexis | 61.25 Mn | -53.45 Mn | - | 8.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.01 Mn |
| Mar 31, 2026 | 16.94 Mn |
| Dec 31, 2025 | 8.13 Mn |
| Sep 30, 2025 | 8.74 Mn |
| Jun 30, 2025 | 10.93 Mn |
| Mar 31, 2025 | 8.87 Mn |
| Dec 31, 2024 | 9.03 Mn |
| Sep 30, 2024 | 10.98 Mn |
| Jun 30, 2024 | 9.97 Mn |
| Mar 31, 2024 | 10.88 Mn |
| Dec 31, 2023 | 28.86 Mn |
| Sep 30, 2023 | 11.86 Mn |
| Jun 30, 2023 | 14.94 Mn |
| Mar 31, 2023 | 11.81 Mn |
| Dec 31, 2022 | 24.01 Mn |
| Sep 30, 2022 | 23.36 Mn |
| Jun 30, 2022 | 23.06 Mn |
| Mar 31, 2022 | 20.43 Mn |
| Dec 31, 2021 | 22.89 Mn |
| Sep 30, 2021 | 19.96 Mn |